VCYT
VERACYTE, INC.
NASDAQ · Healthcare · Biotechnology · US
$39.80
−1.91%Forward multiples
Based on analyst estimates
- P/E forward
- 22.14x
- P/E 2026E
- 20.82x
- P/E 2027E
- 20.42x
- P/E 2028E
- 19.18x
- P/S forward
- 5.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- 27.64x
- PEG TTM
- 1.11x
- Price / book
- 2.30x
- Price / sales
- 5.69x
- Price / cash flow
- 17.93x
Enterprise value
- Enterprise value
- $2.8B
- EV / sales
- 4.90x
- EV / EBITDA
- 21.22x
- EV / EBIT
- 28.77x
- Market cap
- $3.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026